Particulars |
|
|
|
Company Name
| Astrazeneca Pharma India Ltd
| Year End
| 202403
|
Full Year |
Equity (₹ Cr.) |
5.00 |
B.V. (₹) |
271.70 |
Sales(₹ Cr.) |
1,295.53 |
NP (₹ Cr.) |
149.06 |
NP Var% |
18.00 |
Div% |
1,200.00 |
CPS(₹) |
65.60 |
EPS (₹) |
59.60 |
Traded Value(₹ Lakhs) |
99.16 |
52 Week High |
8,140.00 |
52 Week Low |
4,050.00 |
Price BSE |
7,266.00 |
Price NSE |
7,263.00 |
Market Capital (₹ Cr.) |
18,165.25 |
P/C Ratio |
110.80 |
P/E Ratio |
121.90 |
Price Vs.BV |
26.74 |
|
Latest Quarter |
Year End |
202409 |
Sales (₹ Cr.) |
408.00 |
NP(₹ Cr.) |
38.43 |
NP Var % |
-6.00 |
Trailing Twelve Months |
Year End |
202409 |
Sales |
1,484.51 |
OPM |
10.44 |
NP |
128.73 |
NP Var% |
-25.58 |
EPS |
51.49 |
PE |
141.12 |
|
|